FJ Velasco, A Ramos, B Peixe, F Açucena, Sousa D, Guerreiro H, Conde e Silva J.

Serviço de Gastrenterologia do Hospital Distrital de Faro E.P.E.

Texto Completo disponível apenas em PDF

Full text only available in PDF format

Bibliografia

1. Junquera F, Feu F, Papo M, Videla S, Armengol JR, Bordas JM, e al. A multicenter, randomized clinical of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodisplasia. Gastroenterology 2001; 121:1073-1079        [ Links ]

2. Humphrey Hodgson. Hormonal therapy for gastrointestinal angiodysplasia. Lancet 2002; 359:1630-1631.

3. Madanick RD, Barkin JS. Hormonal therapy in angiodysplasia: Should we completely abandon its use? Gastroenterology 2002; 23:2156.

4. Menefee MG, Flassa HC, Glueck HI, Hogg SP. Hereditary hemorrhagic angiectasia (Osler-Weber-Rendu disease): an electron microscopic study of the vascular lesions before and after with hormones. Arch Otolaryngol 1975; 101: 246-51.

5. Harrison DFN. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope 1982; 92:564-70.

6. Richtsmeier W, Weaver G, Streck W, Jacobson H, Dewell R, Olson J. Otolaryngol Head Neck Surg. 1984; 92(5):564-70.

7. Kjjeldsen AD, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorragic telangiectasia. Am J Gastroenterol. 2000; 95(2):215-218.